Sudeep Pharma Limited (NSE:SUDEEPPHRM)

Market Cap	65.88B
Revenue (ttm)	6.17B +34.4%
Net Income	1.68B +26.3%
EPS	15.40 +25.4%
Shares Out	112.95M
PE Ratio	37.89
Forward PE	34.98
Dividend	n/a
Ex-Dividend Date	n/a

Volume	18,364
Average Volume	90,418
Open	582.30
Previous Close	584.65
Day's Range	581.00 - 596.50
52-Week Range	524.05 - 795.00
Beta	n/a
RSI	36.59
Earnings Date	Feb 6, 2026

About Sudeep Pharma

Sudeep Pharma Limited manufactures and sells excipients and specialty ingredients for the pharmaceutical, food, and nutrition industries in United States, Europe, United Kingdom, and Latin America. The company provides mineral salts, such as calcium, zinc, iron, potassium, magnesium, sodium, and copper to a range of health-focused applications; and calcium carbonate, which is used as an active pharmaceutical ingredient for various therapeutic applications. It also offers micronutrient premixes, encapsulated ingredients, liposomal and spray-drie...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 1989
• Employees: 740
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: SUDEEPPHRM

Financial Performance

In fiscal year 2025, Sudeep Pharma's revenue was 5.02 billion, an increase of 9.30% compared to the previous year's 4.59 billion. Earnings were 1.39 billion, an increase of 4.14%.